It was announced after the close on Friday, the FDA was delaying the approval of Eli Lilly's arthritis drug.
Credit Suisse is bullish on Eli Lilly and Co (NYSE: LLY ), saying the recent FDA delay on rheumatoid arthritis drug baricitinib is only a short-term setback for the pharma major . But, the brokerage acknowledges ...
Biotech stocks had a rough year in 2016, overall. The new year has brought new optimism among some investors, but there are still reasons to be cautious.
INCY : Summary for Incyte Corporation - Yahoo Finance
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||113.95 x 100|
|Ask||114.08 x 200|
|Day's Range||113.12 - 114.79|
|52 Week Range||55.00 - 121.18|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||310.76|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|